. 2015 Mar 12;9(3):e0003574. doi: 10.1371/journal.pntd.0003574

Table 3. Solicited adverse events among adults and children following 14 and 28 day dosing intervals.

	14 day interval		p value
Number of AEs within 3 days after first vaccine dose	2 ^a	6 ^b	0.39
Number of AEs within 3 days after second vaccine dose	2 ^c	0	0.32
Number (%) of participants with ≥ 1 AEs 3 days following dosing regimen	2/178 (1.1%)	3/178 (1.7%)	1
Number (%) of participants with SAEs 28 days following dosing regimen	0/178 (0%)	0/178 (0%)	--

^a mild fever (n = 1) and mild headache (n = 1)

^b mild diarrhea (n = 1), mild nausea (n = 1), mild general ill feeling (n = 1), mild fever (n = 2), mild vomiting (n = 1)

^c moderate diarrhea (n = 1), mild general ill feeling (n = 1)